Kestra Medical Technologies logo
Kestra Medical Technologies
KMTS | NASDAQ
Chart Builder DCF Calculator
$27.97
-$0.67 (-2.34%)
At close: Nov 16, 2026, 4:00 PM ET
$27.97
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Kestra Medical Technologies Company Profile

Company profile explained

Company Profile

Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.

Key Executives

Name Position
Brian Webster Founder, President, Chief Executive Officer & Director
Gordon Teddy Chief Information Officer
Vaseem Mahboob Chief Financial Officer
Alfred J. Ford Jr. Chief Commercial Officer
Debra Schotz Senior Vice President of Marketing
Jeffrey Laub Senior Vice President of Operations
Neil Bhalodkar Vice President of Investor Relations
R. Curtis Kopf Senior Vice President of Customer Experience
Timothy Moran Chief Business Officer
Traci S. Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director

Latest SEC Filings

Date Type Title
Oct 29, 2026 4 Filing
Oct 29, 2026 4 Filing
Oct 22, 2026 4 Filing
Oct 22, 2026 4 Filing
Oct 01, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 21, 2026 144 Filing
Sep 14, 2026 10-Q Quarterly Report
Sep 14, 2026 8-K Current Report
Sep 10, 2026 4 Filing
View All SEC Filings ➞
Kestra Medical Technologies
Kestra Medical Technologies logo
Country United States
IPO Date Mar 6, 2025
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 443
CEO Brian Webster

Contact Details

3933 Lake Washington Blvd NE Kirkland, Washington 98033 United States

Stock Details

Ticker Symbol KMTS
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
CIK Code 0001877184
CUSIP Number G52441105
ISIN Number BMG524411052
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.